New Jersey governor and possible GOP presidential candidate Chris Christie insists he's been a victim of liberal media bias over Bridgegate.» Read More
The Weather Channel's Jen Carfagno reports on Groundhog Day.
Is President Obama leaning left ahead of his budget proposal? Ben White, Politico, discusses what could be a turbulent rollout.
The case of Antonio Weiss shows that Congress will not confirm successful candidates from Wall Street, Evercore CEO Ralph Schlosstein told CNBC.
Evercore Partners Ralph Schlosstein told CNBC that politicians have put a target on the backs of those who are financially successful.
Providing choice is key to getting young people to actually pay for programming, Time Warner Chairman and CEO Jeff Bewkes tells CNBC.
Strategist Bob Doll tells CNBC it's all about the negative impact of lower oil prices and the rising dollar on earnings.
Valuations for energy companies may not have fallen far enough to spark dealmaking, two analysts tell CNBC.
The drugmaker has engaged in $100 billion of M&A in the last year, but CEO Brent Saunders told CNBC it is committed to innovation.
Eli Lilly has been on a roller-coaster ride in the wake of patent expirations, CEO John Lechleiter tells CNBC.
CNBC's Jim Cramer is watching shares of Google and Amazon ahead of the opening bell.
Brian Rolapp, NFL Network CEO, discusses Sunday's Super Bowl, social media and head injuries in the NFL.
Bob Doll, Nuveen Asset Management, discusses how low oil prices and a strong dollar is impacting earning and prompting market volatility. And Doll explains why the Fed needs to raise interest rates.
CNBC's Rick Santelli breaks down the numbers on growth in the U.S. economy.
Jeff Bewkes, Time Warner chairman & CEO, shares his thoughts on mergers and making money in the media sector.
TV content is getting better, says Jeff Bewkes, Time Warner chairman & CEO, discussing video content, bundling, and the future of cable mergers.
Brent Saunders, Actavis CEO, discusses how Actavis is leading the way in growth pharma and talks about its M&A strategy.
Robert Hugin, Celgene chairman & CEO, discusses his company's efforts to fight cancer and discusses promising drugs in the pipeline.
John Lechleiter, Eli Lilly CEO, runs through the quarterly numbers and provides insight to products coming off patents, R&D, and new Alzheimer's drugs in the pipeline.
Fred Hassan, Warburg Pincus Partner, talks about the way information technology is changing the face of modern medicine and transforming the health care industry.
CNBC's Meg Tirrell has details on the meeting today between President Obama and drugmakers to discuss how to improve health and treat disease.
Get the best of CNBC in your inbox